NEKTAR THERAPEUTICS Business Finance Contracts & Agreements
50 Contracts & Agreements
- Deposit Agreements (1 contract)
- Exchange Agreements (9)
- Indenture Agreements (5)
- Loan Agreements (1)
- Note Agreements (5)
- Pledge Agreements (4)
- Purchase Agreements (4)
- Registration Rights Agreements (2)
- Security Agreements (4)
- Share Agreements (2)
- Shareholders Agreements (1)
- Stock Agreements (10)
- Underwriting Agreements (2)
- Purchase and Sale Agreement, dated December 16, 2020, by and between entities managed by Healthcare Royalty Management, LLC and Nektar Therapeutics (Filed With SEC on February 26, 2021)
- Nektar Therapeutics Amended and Restated Employee Stock Purchase Plan (Filed With SEC on August 7, 2020)
- Share Purchase Agreement dated February 13, 2018, by and between Nektar Therapeutics and Bristol-Myers Squibb Company (Filed With SEC on February 14, 2018)
- NEKTAR THERAPEUTICS 13,000,000Shares of Common Stock, $0.0001 par value per share Underwriting Agreement (Filed With SEC on October 19, 2016)
- $250,000,000 Nektar Therapeutics 7.750% Senior Secured Notes due 2020 PURCHASE AGREEMENT (Filed With SEC on October 6, 2015)
- NEKTAR THERAPEUTICS 7.75% SENIOR SECURED NOTES DUE 2020 (Filed With SEC on October 6, 2015)
- PLEDGE AND SECURITY AGREEMENT (Filed With SEC on October 6, 2015)
- NektarTherapeutics EmployeeStock Purchase Plan Adoptedby the Board of Directors February 10, 1994 Approvedby Stockholders February 18, 1994 Amendedand Restated May 10, 2002... (Filed With SEC on June 27, 2014)
- TERM LOAN AND SECURITY AGREEMENT among NEKTAR THERAPEUTICS, as Borrower, theGuarantors from time to time party hereto, as Guarantors, and ASTRAZENECA AB, as Agent October 7, 2013... (Filed With SEC on February 27, 2014)
- NEKTAR THERAPEUTICS 8,500,000Shares of Common Stock, $0.0001 par value per share Underwriting Agreement (Filed With SEC on January 28, 2014)
- PLEDGE AND SECURITY AGREEMENT (Filed With SEC on March 1, 2013)
- NEKTAR THERAPEUTICS 12.00% SENIOR SECURED NOTES DUE 2017 INDENTURE Dated as of July 11, 2012 Wells Fargo Bank, National Association Trustee and Collateral Agent (Filed With SEC on July 11, 2012)
- PLEDGE AND SECURITY AGREEMENT (Filed With SEC on July 11, 2012)
- ESCROW AND DEPOSIT ACCOUNT CONTROL AGREEMENT among NEKTAR THERAPEUTICS, WELLS FARGO BANK, NATIONAL ASSOCIATION as Collateral Agent, and WELLS FARGO BANK, NATIONAL ASSOCIATION as... (Filed With SEC on July 11, 2012)
- $125,000,000 Nektar Therapeutics 12.000% Senior Secured Notes due 2017 PURCHASE AGREEMENT (Filed With SEC on July 10, 2012)
- PURCHASE AND SALE AGREEMENT dated as of February 24, 2012 between NEKTAR THERAPEUTICS and RPI FINANCE TRUST (Filed With SEC on May 4, 2012)
- NEKTAR THERAPEUTICS 2008 EQUITY INCENTIVEPLAN Adopted by the Board of Directors on March 20, 2008 Approved by the Shareholders on June 6, 2008 Amended by the Board of Directors on... (Filed With SEC on February 29, 2012)
- 19,000,000Shares NEKTARTHERAPEUTICS CommonStock ($0.0001par value per Share) UNDERWRITINGAGREEMENT (Filed With SEC on January 21, 2011)
- NektarTherapeutics EmployeeStock Purchase Plan Adoptedby the Board of Directors February 10, 1994 ApprovedbyStockholders February 18, 1994 Amendedand Restated May 10, 2002... (Filed With SEC on July 6, 2010)
- NEKTAR THERAPEUTICS 2000 EQUITYINCENTIVE PLAN RESTRICTED STOCK UNITAGREEMENT (Filed With SEC on November 9, 2007)
- NEKTAR THERAPEUTICS 2000 EQUITYINCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on November 9, 2007)
- NEKTAR THERAPEUTICS 2000 EQUITYINCENTIVE PLAN RESTRICTED STOCK UNIT GRANTNOTICE (Filed With SEC on March 16, 2006)
- INDENTURE between (Filed With SEC on September 28, 2005)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 28, 2005)
- NEKTAR THERAPEUTICS (a Delaware corporation) $275,000,000 3.25% Convertible Subordinated Notes due 2012 PURCHASE AGREEMENT (Filed With SEC on September 28, 2005)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 17, 2005)
- NEKTAR THERAPEUTICS (formerly known as Inhale Therapeutic Systems, Inc.) 2000 NON-OFFICER EQUITY INCENTIVEPLAN Adopted August 18, 1998 Amended February 23, 1999 Amended December... (Filed With SEC on August 5, 2004)
- NEKTARTHERAPEUTICS (a Delawarecorporation) 9,500,000 Sharesof Common Stock UNDERWRITINGAGREEMENT (Filed With SEC on March 11, 2004)
- PLEDGE AGREEMENT (Filed With SEC on November 3, 2003)
- EXCHANGEAGREEMENT (Filed With SEC on November 3, 2003)
- EXCHANGEAGREEMENT (Filed With SEC on November 3, 2003)
- EXCHANGEAGREEMENT (Filed With SEC on November 3, 2003)
- FIRSTSUPPLEMENTAL INDENTURE (Filed With SEC on October 20, 2003)
- PLEDGE AGREEMENT (Filed With SEC on October 20, 2003)
- EXCHANGEAGREEMENT (Filed With SEC on October 20, 2003)
- AMENDMENT NO. 1 TO EXCHANGE AGREEMENT (Filed With SEC on October 20, 2003)
- INDENTURE between NEKTARTHERAPEUTICS, asIssuer and J.P. MORGANTRUST COMPANY, NATIONAL ASSOCIATION asTrustee 3%CONVERTIBLE SUBORDINATED NOTES DUE 2010 Datedas of October 9, 2003... (Filed With SEC on October 10, 2003)
- FORM OF SECURITY [FACE OF SECURITY] (Filed With SEC on October 10, 2003)
- PLEDGE AGREEMENT (Filed With SEC on October 10, 2003)
- EXCHANGEAGREEMENT (Filed With SEC on October 10, 2003)
